• OPEN AN ACCOUNT
Indian Indices
Sensex
72,472.33 879.09
( 1.23%)
Global Indices
Nasdaq
51,671.07 418.43
(0.82%)
Dow Jones
7,831.57 45.21
(0.58%)
Hang Seng
69,084.74 42.63
(0.06%)
Nikkei 225
10,559.70 118.10
(1.13%)
Forex
USD-INR
96.78 0.11
(0.12%)
EUR-INR
108.39 0.07
(0.07%)
GBP-INR
127.86 0.00
(0.00%)
JPY-INR
0.61 0.00
(0.21%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
18.604918
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
41.27
79.3
EPS(TTM)
Face Value()
Div & Yield %
1.26
10
0
 

Gufic BioSciences receives ESG rating of 62
Sep 28,2026
Gufic BioSciences announced that Crisil ESG Ratings & Analytics (Crisil), a SEBI Registered Category – I Environmental, Social and Governance (ESG) Rating Provider vide its report dated 25 September 2026, received by the Company on 28 September 2026, has assigned an overall ESG rating of CRISIL ESG 62 (Category: Strong) to the Company for FY 2025-26.